Also trades as: SHL.DE (XETRA) · $vol 42M · 0PMJ.L (LSE) · $vol 17M · SEMHF (OTC) · $vol 0M

$21.29

+0.20 (+0.95%)

Weekly Expected Move ±3.0%

$20 $21 $21 $22 $23

OTC · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 35 · $23.8B mcap · 267M float · 0.037% daily turnover · Short 49% of daily vol

Revenue

$22.0B -1.5% ▼

5Y CAGR: +8.8%

Gross Profit

$8.5B +0.5% ▲

5Y CAGR: +8.8%

Operating Income

$3.2B -1.9% ▼

5Y CAGR: +9.7%

Net Income

$2.0B +4.1% ▲

5Y CAGR: +7.5%

EPS (Diluted)

$0.90 +4.0% ▲

5Y CAGR: +4.9%

EBITDA

$4.3B +2.3% ▲

5Y CAGR: +8.7%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$18.0B	$21.7B	$21.7B	$22.4B	$22.0B
YoY Growth	+24.5%	+20.7%	-0.2%	+3.2%	-1.5%
Cost of Revenue	$11.0B	$13.6B	$14.0B	$13.9B	$13.5B
Gross Profit	$7.0B	$8.1B	$7.7B	$8.5B	$8.5B
Gross Margin	38.6%	37.5%	35.6%	37.9%	38.6%
R&D Expenses	$1.5B	$1.8B	$1.9B	$1.9B	$1.8B
SG&A Expenses	$2.6B	$3.3B	$3.4B	$3.2B	$3.4B
Operating Expenses	$4.2B	$5.1B	$5.3B	$5.2B	$5.3B
Operating Income	$2.8B	$3.1B	$2.4B	$3.3B	$3.2B
Operating Margin	15.4%	14.1%	11.3%	14.8%	14.7%
Interest Expense	$83M	$118M	$296M	$476M	$401M
Income Before Tax	$2.4B	$2.8B	$1.9B	$2.5B	$2.7B
Tax Expense	$658M	$746M	$403M	$564M	$646M
Net Income	$1.7B	$2.0B	$1.5B	$1.9B	$2.0B
Net Margin	9.6%	9.4%	7.0%	8.7%	9.2%
EPS (Diluted)	$0.78	$0.91	$0.67	$0.87	$0.90
EBITDA	$3.5B	$4.3B	$3.8B	$4.2B	$4.3B
Shares Outstanding	2.21B	2.26B	2.25B	2.25B	2.25B

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$6.3B	$5.5B	$5.9B	$5.7B	$5.0B	$5.4B	$5.8B	$5.8B
Cost of Revenue	$3.9B	$3.3B	$3.6B	$3.5B	$3.1B	$3.3B	$3.6B	$3.3B
Gross Profit	$2.4B	$2.2B	$2.3B	$2.2B	$2.4B	$2.1B	$2.2B	$2.5B
Gross Margin	38.0%	39.3%	39.3%	38.5%	47.6%	38.4%	37.7%	42.5%
R&D Expenses	$496M	$481M	$485M	$493M	$498M	$472M	$495M	$488M
SG&A Expenses	$635M	$940M	$943M	$947M	$935M	$868M	$913M	$1.0B
Operating Expenses	$1.1B	$1.4B	$1.4B	$1.3B	$1.1B	$1.3B	$1.4B	$1.5B
Operating Income	$1.3B	$731M	$895M	$872M	$740M	$717M	$767M	$954M
Operating Margin	20.2%	13.3%	15.1%	15.4%	14.9%	13.4%	13.3%	16.6%
Interest Expense	$142M	$108M	$104M	$104M	$131M	$95M	$102M	$0
Income Before Tax	$844M	$617M	$730M	$736M	$606M	$597M	$655M	$877M
Tax Expense	$220M	$139M	$193M	$180M	$173M	$146M	$134M	$201M
Net Income	$616M	$474M	$530M	$552M	$587M	$446M	$514M	$669M
Net Margin	9.7%	8.6%	9.0%	9.7%	11.8%	8.3%	8.9%	11.6%
EPS (Diluted)	$0.28	$0.21	$0.24	$0.25	$0.26	$0.20	$0.12	$0.30
EBITDA	$1.3B	$1.0B	$1.1B	$1.2B	$1.2B	$989M	$1.0B	$1.3B
Shares Outstanding	2.24B	2.26B	2.26B	2.25B	2.23B	2.25B	4.50B	2.23B

SMMNY OTC